Literature DB >> 33073599

Changing clinical patterns of Rhegmatogeneous Retinal Detachments during the COVID19 pandemic lockdown in the North West of the UK.

Kirti M Jasani1, Tsveta Ivanova1, Francesco Sabatino1, Niall Patton1, Felipe Dhawahir-Scala1, Grace Chew1, Stephen Charles1, Philip David2, Andrew Davies3, Assad Jalil1.   

Abstract

INTRODUCTION: The UK Government imposed a COVID19 lockdown (LD) restricting all but essential activities from 24th March 2020. Subsequently, there has been a significant reduction in casualty attendances nationwide including for ophthalmic emergencies. We aim to study the presentation of rhegmatogenous retinal detachments (RRD) and significant vitreous haemorrhage caused by posterior vitreous detachment (PVD-VH) in three tertiary centres covering most of the North West of England in the 6 weeks before and during the lockdown.
METHODS: A retrospective multicenter non-randomised consecutive case series study was designed to collect information on all cases of RRD and PVD-VH requiring surgery presenting to the vitreoretinal departments of Manchester Royal Eye Hospital, East Lancashire NHS Foundation Trust and the Lancashire NHS Foundation Trust from 11th February to 4th May 2020.
RESULTS: A total of 137 eyes of 137 patients were identified between the three centres of which 132 eyes were operated for RRD. Of these, 86 (64.7%) were operated pre-LD compared with 46 eyes (34.8%) during LD. Forty-five out of 86 eyes (52.3%) were macula-off pre-LD compared with 31 out of 46 eyes (67.3%) during LD (p = 0.06). There was lower proportion of non-PVD related RRD during LD (11 pre-LD to 1 during LD, p = 0.05). PVR was present in four cases during LD compared to 2 before (p = 0.19).
CONCLUSION: There was a clinically significant reduction in the overall incidence of RRD in our centres with an increase in the proportion of macula-off and proliferative vitreoretinopathy during the LD period compared to a similar period before.

Entities:  

Keywords:  COVID19; Retinal detachment; lockdown; ocular trauma; rhegmatogeneous retinal detachment; vitrectomy

Mesh:

Year:  2020        PMID: 33073599     DOI: 10.1177/1120672120965480

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

Review 1.  How should we report the foveal status in eyes with "macula-off" retinal detachment?

Authors:  Julian E Klaas; Jakob Siedlecki; David H Steel; D Alistair H Laidlaw; Siegfried Priglinger
Journal:  Eye (Lond)       Date:  2022-05-03       Impact factor: 3.775

2.  The Impact of Three Waves of the COVID-19 Pandemic on the Characteristics of Primary Rhegmatogenous Retinal Detachments at a Tertiary Referral Centre.

Authors:  Diana Dmuchowska; Izabela Cwalina; Pawel Krasnicki; Joanna Konopinska; Emil Saeed; Zofia Mariak; Iwona Obuchowska
Journal:  Clin Ophthalmol       Date:  2021-08-16

3.  Patients' perspective on emergency treatment of ophthalmologic diseases during the first phase of SARS-CoV2 pandemic in a tertiary referral center in Germany - the COVID-DETOUR questionnaire study.

Authors:  Christoph Ehlken; Constantin von Medem; Maya Lüdemann; Anna Maria Kirsch; Johann Baptist Roider
Journal:  BMC Ophthalmol       Date:  2021-08-16       Impact factor: 2.209

4.  Clinical patterns of rhegmatogenous retinal detachment during the first state of emergency for the COVID-19 pandemic in a Tokyo center.

Authors:  Toshiaki Hirakata; Tianxiang Huang; Yoshimune Hiratsuka; Shutaro Yamamoto; Akira Inoue; Akira Murakami
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

5.  Impact of COVID-19 lockdown on Retinal Surgeries.

Authors:  Muhammad Amer Awan; Fiza Shaheen; Fatima Mohsin
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

6.  Effect of COVID-19 Lockdowns on Eye Emergency Department, Increasing Prevalence of Uveitis and Optic Neuritis in the COVID-19 Era.

Authors:  Joanna Przybek-Skrzypecka; Alina Szewczuk; Anna Kamińska; Janusz Skrzypecki; Aleksandra Pyziak-Skupień; Jacek Paweł Szaflik
Journal:  Healthcare (Basel)       Date:  2022-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.